Questran and Deformity - a phase IV clinical study of FDA data

Summary:

Deformity is reported as a side effect among people who take Questran (cholestyramine), especially for people who are female, 40-49 old, also take Protonix, and have Behcet's syndrome.

The phase IV clinical study analyzes which people have Deformity when taking Questran. It is created by eHealthMe based on reports of 4,400 people who have side effects when taking Questran from the FDA, and is updated regularly.

What is Questran?

Questran has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 4,490 Questran users. Check the latest studies of Questran.

What is Deformity?

Deformity (disfigurement) is found to be associated with 933 drugs and 701 conditions by eHealthMe. Check the latest studies of Deformity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

4,400 people reported to have side effects when taking Questran.
Among them, 12 people (0.27%) have Deformity.

Among these 12 people:

What is the gender of people who have Deformity when taking Questran? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Deformity when taking Questran? *

What are other drugs people take besides Questran? *

What are other side effects people have besides Deformity? *

Joint Pain: 11 people, 91.67%
Fatigue (feeling of tiredness): 11 people, 91.67%
Pain: 11 people, 91.67%
Skin Ulcer: 10 people, 83.33%
Muscle Aches (muscle pain): 10 people, 83.33%
Gait Disturbance: 8 people, 66.67%
Emotional Distress: 7 people, 58.33%
Impaired Healing: 7 people, 58.33%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 7 people, 58.33%
Foot Fracture: 7 people, 58.33%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 50.00%
Behcet's Syndrome (involves inflammation of the blood vessels): 6 people, 50.00%
Nuclear Magnetic Resonance Imaging Abdominal: 1 person, 8.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Cardiac Failure Congestive: 1 person, 8.33%
Abdominal Discomfort: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Questran and have Deformity?

- Check whether Deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Questran:

Questran (4,490 reports)

Deformity treatments and more:

Deformity (13,758 reports)

Browse all side effects of Questran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deformity:

Deformity (933 drugs)

Browse all the conditions that are associated with Deformity:

Deformity (701 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cholestyramine (the active ingredients of Questran) and Questran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.